Diphtheria Toxoid Adsorbed
Status: withdrawn from the U.S. market
Organizations involved:
BioPort Corp. – Manuf.; R&D; Tech.
Michigan Biologics Products Institute – Former
Cross ref.: See the Diphtheria Toxoid Products entry above.
Description: Diphtheria Toxoid Adsorbed from BioPort is an aqueous formulation of purified, aluminum hydroxide-adsorbed, formaldehyde-inactivated Corynebacterium diph-theriae toxin (toxoid) obtained from culture of C. diphtheriae (Park-William strain no. 8) bacterium. The toxin is separated from culture media using the Pillemer alcohol-fractionation method, and further purified using metaphosphoric acid, followed by inactivation with formaldehyde, and adsorption onto aluminum hydroxide adjuvant. The product contains at >2 antitoxin units/mL as determined by guinea pig potency and detoxification assays.
Nomenclature: Diphtheria Toxoid/BioPort [BIO]; Diphtheria Toxoid Adsorbed [FDA USAN]; Diphtheria Toxoid Aluminum Phosphate Adsorbed [FDA former]
Companies.: This vaccine was formerly manufactured by the Michigan Department of Public Health (Michigan Biologics Products Institute), now BioPort Corp., CBER/FDA est. 1260.
SmithKline Beecham Corp. (now GlaxoSmithKline Inc.) previously marketed a Diphtheria and Tetanus Toxoids and Pertussis Vaccine Adsorbed (DTP) product in the U.S., using components manufactured by the Michigan Biologics Products Institute (now BioPort Corp.).
FDA class: Biologic PLA
CBER class: Bacterial Antigens and Vaccines
Approvals: Date = 19560818; first approval granted to Michigan Department of Public Health, according to 1979 Office of Technology Assessment (OTA) vaccines approval list
Date = 19700827; first approval, according to the CBER/FDA database. However, an FDA letter to the company on this date states that approval was revoked and granted (reissued) using a new (the current) FDA proper name
Date = 19981112; approval revoked and granted (reissued) to new owner, BioPort Corp.
Date = 20001020; license voluntarily revoked
Indications: product insert/labeling not available
Status: The product is no longer approved, manufactured, or marketed. License revocation was announced in the Federal Register, May 29, 2001, 66 (103), p. 29148-9.
Companies involvement:
Full monograph
419 Diphtheria Toxoid/BioPort
Nomenclature:
Diphtheria Toxoid/BioPort [BIO]
Diphtheria Toxoid Adsorbed [FDA USAN]
Diphtheria Toxoid Aluminum Phosphate Adsorbed [FDA former]
Corynebacterium diphtheriae vaccine [SY]
FDA Class: Biologic PLA
Year of approval (FDA) = 1956
Date of 1st FDA approval = 19560818
(in format YYYYMMDD)
Index Terms:
biopharmaceutical products
vaccines, bacterial
vaccines, subunit
vaccines, toxoids (inactivated toxins)
bacterial culture <!-- bacterialculture -->
Corynebacterium diphtheriae
Park-William no. 8, Corynebacterium diphtheriae
diphtheria toxin
Diphtheria Toxoid
ethanol
formaldehyde
phosphoric acid, meta-
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
North American coral snake
North American coral snake
EU000 Not yet/Never filed with EU
UM999 Not Available/Not Marketed in US
US011 Approved Formerly in US/withdrawn
EM999 Not Available/Not Marketed in EU
Copyright© 2020, Biotechnology Information Institute